ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

TATA NIFTY MIDSMALL HEALTHCARE INDEX FUND

TATA Tata Mutual Fund Apr 2024 — Sep 2026 29 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹221 CrAt NSE closes, Sep 2026
Companies held3030 with an NSE price
Top 10 holdings58.7%Of the equity shown here
Largest holding11.8%Laurus Labs Limited
12-month turnover5.7%Estimated from 12 monthly disclosures · compare

Days to sell half: 0.3 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

29 priced months, Apr 2024 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

58.7% now, 57.8% in Sep 2025 · highest 62.4%, lowest 57.8%

Companies held

30 now, 30 in Sep 2025 · largest single holding 11.8% of equity

How it trades: no clear lean toward recent winners or losers (score -0.01 over 27 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Sector mix

Share of the equity shown · NSE industry

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. Motilal Oswal Nifty MidSmall Healthcare Index FundMotilal Oswal · 30 shared100.0%
  2. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 30 shared48.4%
  3. Mirae Asset Healthcare FundMirae Asset · 17 shared47.6%
  4. Baroda BNP Paribas Health and Wellness FundBaroda BNP Paribas · 15 shared44.0%
  5. Nippon India Nifty Pharma ETFNippon India · 14 shared43.1%
  6. ICICI Prudential Nifty Pharma Index FundICICI Prudential · 14 shared43.1%
  7. Bandhan BSE Healthcare Index FundBandhan · 30 shared40.8%
  8. Motilal Oswal BSE Healthcare ETFMotilal Oswal · 30 shared40.8%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 1 Companies added
Complete exits 1 Companies sold out
Increases 29 More shares than last month
Reductions 0 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Laurus Labs Limited Healthcare Mid Cap 11.82% 26.12 Cr 0.01 Cr by Apr 2024 (29 mo+)
Lupin Limited Healthcare Mid Cap 7.56% 16.70 Cr 82,281 by Apr 2024 (29 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 7.08% 15.65 Cr 93,615 by Apr 2024 (29 mo+)
Fortis Healthcare Limited Healthcare Mid Cap 6.15% 13.59 Cr 0.02 Cr by Apr 2024 (29 mo+)
Glenmark Pharmaceuticals Limited Healthcare Mid Cap 5.39% 11.91 Cr 51,001 by Apr 2024 (29 mo+)
Alkem Laboratories Limited Healthcare Mid Cap 4.77% 10.55 Cr 20,425 by Apr 2024 (29 mo+)
Mankind Pharma Limited Healthcare Mid Cap 4.35% 9.61 Cr 38,387 by Apr 2024 (29 mo+)
IPCA Laboratories Limited Healthcare Mid Cap 4.10% 9.07 Cr 47,059 by Apr 2024 (29 mo+)
Biocon Limited Healthcare Mid Cap 3.96% 8.74 Cr 0.02 Cr by Apr 2024 (29 mo+)
Gland Pharma Limited Healthcare Small Cap 3.54% 7.83 Cr 26,996 by Apr 2024 (29 mo+)
Sai Life Sciences Limited Healthcare Small Cap 3.23% 7.14 Cr 46,851 Mar 2026 (7 mo)
Krishna Institute of Medical Sciences Limited Healthcare Small Cap 3.05% 6.75 Cr 90,397 by Apr 2024 (29 mo+)
Aster DM Quality Care Limited Healthcare Small Cap 2.86% 6.31 Cr 90,546 by Apr 2024 (29 mo+)
Neuland Laboratories Limited Healthcare Small Cap 2.82% 6.24 Cr 2,921 Mar 2025 (19 mo)
Wockhardt Limited Healthcare Small Cap 2.68% 5.92 Cr 27,982 Sep 2025 (13 mo)
Acutaas Chemicals Limited Healthcare Small Cap 2.61% 5.76 Cr 17,578 Jul 2026 (3 mo)
Ajanta Pharma Limited Healthcare Small Cap 2.53% 5.59 Cr 15,443 by Apr 2024 (29 mo+)
Dr. Lal Path Labs Ltd. Healthcare Small Cap 2.38% 5.25 Cr 26,429 by Apr 2024 (29 mo+)
Abbott India Limited Healthcare Mid Cap 2.17% 4.79 Cr 1,765 by Apr 2024 (29 mo+)
Piramal Pharma Limited Healthcare Small Cap 1.97% 4.35 Cr 0.02 Cr by Apr 2024 (29 mo+)
Granules India Limited Healthcare Small Cap 1.91% 4.23 Cr 49,956 by Apr 2024 (29 mo+)
Narayana Hrudayalaya Ltd. Healthcare Mid Cap 1.90% 4.19 Cr 23,401 by Apr 2024 (29 mo+)
Global Health Limited Healthcare Mid Cap 1.85% 4.10 Cr 30,022 by Apr 2024 (29 mo+)
Onesource Specialty Pharma Limited Healthcare Small Cap 1.84% 4.06 Cr 26,663 Sep 2025 (13 mo)
GlaxoSmithKline Pharmaceuticals Limited Healthcare Mid Cap 1.76% 3.88 Cr 14,024 by Apr 2024 (29 mo+)
Anthem Biosciences Limited Healthcare Mid Cap 1.42% 3.14 Cr 36,551 Sep 2026 (1 mo)
Natco Pharma Limited Healthcare Small Cap 1.14% 2.52 Cr 30,435 by Apr 2024 (29 mo+)
Cohance Lifesciences Limited Healthcare Small Cap 1.11% 2.45 Cr 55,110 by Apr 2024 (29 mo+)
Syngene International Limited Healthcare Small Cap 1.06% 2.35 Cr 64,320 by Apr 2024 (29 mo+)
Poly Medicure Limited Healthcare Small Cap 0.98% 2.16 Cr 12,934 by Apr 2024 (29 mo+)

Half of its current holdings have been held for 29 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Anthem Biosciences Limited Sep 2026 ▲ New position +36,551
Aster DM Quality Care Limited Sep 2026 ▲ Increasing +6,990
Piramal Pharma Limited Sep 2026 ▲ Increasing +5,153
Pfizer Limited Sep 2026 ▼ Complete exit -5,001
Krishna Institute of Medical Sciences Limited Sep 2026 ▲ Increasing +4,844
Fortis Healthcare Limited Sep 2026 ▲ Increasing +4,521
Laurus Labs Limited Sep 2026 ▲ Increasing +3,525
Aurobindo Pharma Limited Sep 2026 ▲ Increasing +2,267
Lupin Limited Sep 2026 ▲ Increasing +2,136
Granules India Limited Sep 2026 ▲ Increasing +2,065
Global Health Limited Sep 2026 ▲ Increasing +1,763
Syngene International Limited Sep 2026 ▲ Increasing +1,578
Ajanta Pharma Limited Sep 2026 ▲ Increasing +1,544
Cohance Lifesciences Limited Sep 2026 ▲ Increasing +1,415
Sai Life Sciences Limited Sep 2026 ▲ Increasing +1,318
Glenmark Pharmaceuticals Limited Sep 2026 ▲ Increasing +1,311
IPCA Laboratories Limited Sep 2026 ▲ Increasing +1,218
Alkem Laboratories Limited Sep 2026 ▲ Increasing +1,115
Mankind Pharma Limited Sep 2026 ▲ Increasing +1,025
Natco Pharma Limited Sep 2026 ▲ Increasing +785
Wockhardt Limited Sep 2026 ▲ Increasing +729
Onesource Specialty Pharma Limited Sep 2026 ▲ Increasing +711
Dr. Lal Path Labs Ltd. Sep 2026 ▲ Increasing +710
Gland Pharma Limited Sep 2026 ▲ Increasing +700
Biocon Limited Sep 2026 ▲ Increasing +625
Narayana Hrudayalaya Ltd. Sep 2026 ▲ Increasing +599
Acutaas Chemicals Limited Sep 2026 ▲ Increasing +463
GlaxoSmithKline Pharmaceuticals Limited Sep 2026 ▲ Increasing +365
Poly Medicure Limited Sep 2026 ▲ Increasing +329
Neuland Laboratories Limited Sep 2026 ▲ Increasing +75
Abbott India Limited Sep 2026 ▲ Increasing +46
Biocon Limited Aug 2026 ▲ Increasing +9,894
Piramal Pharma Limited Aug 2026 ▲ Increasing +8,625
Fortis Healthcare Limited Aug 2026 ▲ Increasing +7,227
Laurus Labs Limited Aug 2026 ▲ Increasing +5,396
Aurobindo Pharma Limited Aug 2026 ▲ Increasing +3,839
Krishna Institute of Medical Sciences Limited Aug 2026 ▲ Increasing +3,595
Aster DM Quality Care Limited Aug 2026 ▲ Increasing +3,511
Lupin Limited Aug 2026 ▲ Increasing +3,368
Syngene International Limited Aug 2026 ▲ Increasing +2,637
Cohance Lifesciences Limited Aug 2026 ▲ Increasing +2,256
Glenmark Pharmaceuticals Limited Aug 2026 ▲ Increasing +2,088
Granules India Limited Aug 2026 ▲ Increasing +2,012
IPCA Laboratories Limited Aug 2026 ▲ Increasing +1,926
Sai Life Sciences Limited Aug 2026 ▲ Increasing +1,913
Mankind Pharma Limited Aug 2026 ▲ Increasing +1,570
Natco Pharma Limited Aug 2026 ▲ Increasing +1,246
Global Health Limited Aug 2026 ▲ Increasing +1,188
Wockhardt Limited Aug 2026 ▲ Increasing +1,145
Gland Pharma Limited Aug 2026 ▲ Increasing +1,105
Onesource Specialty Pharma Limited Aug 2026 ▲ Increasing +1,090
Dr. Lal Path Labs Ltd. Aug 2026 ▲ Increasing +1,081
Narayana Hrudayalaya Ltd. Aug 2026 ▲ Increasing +958
Alkem Laboratories Limited Aug 2026 ▲ Increasing +811
Acutaas Chemicals Limited Aug 2026 ▲ Increasing +720
Ajanta Pharma Limited Aug 2026 ▲ Increasing +584
GlaxoSmithKline Pharmaceuticals Limited Aug 2026 ▲ Increasing +574
Poly Medicure Limited Aug 2026 ▲ Increasing +530
Pfizer Limited Aug 2026 ▲ Increasing +211
Neuland Laboratories Limited Aug 2026 ▲ Increasing +120
Abbott India Limited Aug 2026 ▲ Increasing +72
J.B. Chemicals & Pharmaceuticals Lt Jul 2026 ▼ Complete exit -23,634
Biocon Limited Jul 2026 ▲ Increasing +19,495
Piramal Pharma Limited Jul 2026 ▲ Increasing +17,730
Acutaas Chemicals Limited Jul 2026 ▲ New position +16,395
Fortis Healthcare Limited Jul 2026 ▲ Increasing +14,290
Laurus Labs Limited Jul 2026 ▲ Increasing +10,669
Krishna Institute of Medical Sciences Limited Jul 2026 ▲ Increasing +10,650
Onesource Specialty Pharma Limited Jul 2026 ▲ Increasing +8,925
Aster DM Quality Care Limited Jul 2026 ▲ Increasing +6,944
Aurobindo Pharma Limited Jul 2026 ▲ Increasing +6,801
Lupin Limited Jul 2026 ▲ Increasing +6,750
Syngene International Limited Jul 2026 ▲ Increasing +5,319
Cohance Lifesciences Limited Jul 2026 ▲ Increasing +4,462
Glenmark Pharmaceuticals Limited Jul 2026 ▲ Increasing +4,130
Granules India Limited Jul 2026 ▲ Increasing +3,980
Sai Life Sciences Limited Jul 2026 ▲ Increasing +3,892
IPCA Laboratories Limited Jul 2026 ▲ Increasing +3,816
Mankind Pharma Limited Jul 2026 ▲ Increasing +3,125
Global Health Limited Jul 2026 ▲ Increasing +2,628
Natco Pharma Limited Jul 2026 ▲ Increasing +2,503
Wockhardt Limited Jul 2026 ▲ Increasing +2,258
Gland Pharma Limited Jul 2026 ▲ Increasing +2,213
Dr. Lal Path Labs Ltd. Jul 2026 ▲ Increasing +2,149
Narayana Hrudayalaya Ltd. Jul 2026 ▲ Increasing +1,895
Alkem Laboratories Limited Jul 2026 ▲ Increasing +1,605
Ajanta Pharma Limited Jul 2026 ▲ Increasing +1,153
GlaxoSmithKline Pharmaceuticals Limited Jul 2026 ▲ Increasing +1,140
Poly Medicure Limited Jul 2026 ▲ Increasing +1,047
Pfizer Limited Jul 2026 ▲ Increasing +417
Neuland Laboratories Limited Jul 2026 ▲ Increasing +237
Abbott India Limited Jul 2026 ▲ Increasing +144
Biocon Limited Jun 2026 ▲ Increasing +369
Piramal Pharma Limited Jun 2026 ▲ Increasing +320
Fortis Healthcare Limited Jun 2026 ▲ Increasing +270
Laurus Labs Limited Jun 2026 ▲ Increasing +201
Aurobindo Pharma Limited Jun 2026 ▲ Increasing +144
Aster DM Quality Care Limited Jun 2026 ▲ Increasing +131
Krishna Institute of Medical Sciences Limited Jun 2026 ▲ Increasing +127
Lupin Limited Jun 2026 ▲ Increasing +126

Changes compare consecutive month-end disclosures for this portfolio only.